← Leaderboards
Ali Azarbarzin
University Of Washington
$3,960,504
Attributed
$4,640,531
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $899.9K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,640,531 · 4
By mechanism
R01$4,159,811 · 2
R21$480,720 · 2
Top collaborators
- Oguz Akbilgic2 shared
- Younghoon Kwon2 shared
- Sharon Marie Lutz1 shared
- Susan S Redline1 shared
Most similar at University Of Washington
Same institution · by research overlap
- Joel Daniel Kaufman$20,790,945
- Bruce M Psaty$64,428,295
- Kenneth A Schenkman$984,459
- Mary E Larimer$29,956,043
- Michael R Von Korff$11,835,615
Others in their field
Other Emerging Leaders on “Clinical Trials”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,363,765
- Beth Baseler · Leidos Biomedical Research, Inc.$207,964,226
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$177,411,785
Research focus
Clinical TrialsIndexingObstructive Sleep ApneaEventResponseSleepMortalityHeart RatePhysiologicalSeveritiesSleep Apnea SyndromesApneaCardiovascular SystemLinkSleep FragmentationsDiagnosisHypoxemiaAffectHypoxiaAdverse OutcomePhenotypePatient SelectionPerformanceAcute
Grant awards (10)
Leveraging research and clinical cohorts to improve Obstructive Sleep Apnea subtyping$818,279
R01 · FY2025 · HL
Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea$653,344
R01 · FY2024 · HL · contact PI
Deep learning of awake and sleep electrocardiography to identify atrial fibrillation risk in sleep apnea$92,786
R21 · FY2024 · HL
Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea$661,307
R01 · FY2023 · HL · contact PI
Novel physiologically-driven phenotypes for the prognosis of cardiovascular outcomes in sleep apnea: Toward precision medicine in sleep health$129,604
R21 · FY2023 · HL · contact PI
Deep learning of awake and sleep electrocardiography to identify atrial fibrillation risk in sleep apnea$108,976
R21 · FY2023 · HL
Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea$661,307
R01 · FY2022 · HL · contact PI
Novel physiologically-driven phenotypes for the prognosis of cardiovascular outcomes in sleep apnea: Toward precision medicine in sleep health$149,354
R21 · FY2022 · HL · contact PI
Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea$661,307
R01 · FY2021 · HL · contact PI
Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea$704,267
R01 · FY2020 · HL · contact PI